Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)
Status:
Completed
Trial end date:
2006-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate improvement in overall survival for the
combination of whole brain radiation therapy (WBRT) plus temozolomide (TMZ) versus WBRT
alone. Secondary objective is to demonstrate an improvement in the time to radiological CNS
progression with the addition of TMZ to WBRT.